×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
HemoSonics' Quantra® Hemostasis System
Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot
Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board
BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®
Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)
Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.
nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.
Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research
FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.
Featured Press Releases
Smart Cups Sets New Goals For Fundraising Round Amid Upcoming Partnerships And Continued Growth
Orsini begins distribution of CASGEVY® (exagamglogene autotemcel), a gene-editing therapy
14 Nov 2024
Orsini has been chosen by Vertex Pharmaceuticals Incorporated to dispense gene-editing therapy
...
Spencer Trask & Co. launches Signal12 for Dry Eye Disease treatment, led by former Aerie executives, advancing Pro-ocular through trials
Nested Therapeutics Receives FDA Clearance for IND Application of NST-628, a Groundbreaking Pan-RAF/MEK Molecular Glue
BioMarin to Present Data Showcasing VOXZOGO® (vosoritide)'s Impact on Bone Health and Quality of Life in Achondroplasia
Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults
Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate
By
PHC Corporation
PHC Corporation
20 Mar 2025
Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience
By
Niagen Bioscience
Niagen Bioscience
19 Mar 2025
Medit introduces SmartX, a new All-on-X solution for digital dentistry
By
Medit
Medit
18 Mar 2025
Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia
By
Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc
17 Mar 2025
Applications Are Being Accepted by the Vilcek Foundation from Immigrants Working in Biomedical Science
By
The Vilcek Foundation
The Vilcek Foundation
17 Mar 2025
Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics
By
Blue Earth Therapeutics Ltd
Blue Earth Therapeutics Ltd
13 Mar 2025
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time
By
Bloomage
Sep 12
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
By
Albertsons Companies
Aug 29
Kedrion Selected by Biotest to Distribute FDA-Approved Immunoglobulin Yimmugo® in the U.S
By
Kedrion Biopharma
Jul 01
March
2025
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
